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Abstract
Objective: To analyze the effect of a Pulmonary Rehabilitation Program (PRP) on the levels of
anxiety and depression and the quality of life of patients with chronic obstructive pulmonary
disease.
Method: Patients with chronic obstructive pulmonary disease (COPD) who completed the PRP
of 3 weekly sessions of 60min duration for 12 weeks, a total of 36 sessions, were assessed usingQuality of life Beck Inventory (BAI and BDI) and Saint George’s Respiratory Questionnaire (SGRQ).
Results: A total of 125 individuals, with an average age of 63.7± 8.8 years, FEV1:
1.17± 0.57 L (43.18± 18.79% predicted), 61.6% male and 38.4% female, were analyzed.
The BAI and BDI before and after PRP were, respectively, 10.15± 6.32 vs. 7.67± 7.21;
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p = 0.0041 and 12.60± 7.99 vs. 8.96± 7.29; p = 0.00016. The results of the SGRQ domains
were, respectively, Before and After symptoms (48.53± 20.41 vs. 32.58± 18.95), Activity
(69.15± 20.79 vs. 52.42± 23.70), Impact (32.92± 18.29 vs. 20.27± 16.70), Total (46.69± 16.90
vs. 32.07± 16.96). When correlating the BDI to the domains of the SGRQ, weak correlations were
observed (Symptoms r = 0.22; p = 0.01; Activity r = 0.28; p = 0.001; Impact r = 0.52; p = 2.72; Total
r = 0.44; p = 0.17). In the same way, weak correlations were observed when correlating the BAI to
the SGRQ (Symptoms r = 0.28; p = 0.0009; Activity r = 0.32; p = 0.0005; Impact r = 0.42; p = 7.33;
Total r = 0.43; p = 0.74).
Conclusion: Although the PRP improves levels of depression and anxiety as well as the quality of
life in patients with COPD, no signiﬁcant correlation of these analyzed variables was observed.
© 2013 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights
reserved.
PALAVRAS-CHAVE
DPOC;
Reabilitac¸ão
pulmonar;
Ansiedade;
Depressão;
Qualidade de vida
Efeito de um Programa de Reabilitac¸ão Pulmonar nos níveis de ansiedade e depressão
e na qualidade de vida de pacientes com doenc¸a pulmonar obstrutiva crônica
Resumo
Objetivo: Analisar o efeito de um programa de reabilitac¸ão pulmonar (PRP) nos níveis de
ansiedade e depressão e na qualidade de vida de doentes com doenc¸a pulmonar obstrutiva
crónica (DPOC).
Método: Os doentes com DPOC que completaram o PRP de 3 sessões semanais de 60 minutos
de durac¸ão, durante 12 semanas, num total de 36 sessões, foram avaliados usando o Inventário
de Beck (BAI e BDI) e o Questionário Saint George na Doenc¸a Respiratória (SGRQ).
Resultados: Foram analisados 125 doentes com uma idade média de 63,7± 8,8, FEV1:
1,17± 0,57 L (43,18± 18,79% previsto), 61,6% homens e 38,4% mulheres. O BAI e o BDI
antes e depois do PRP foram, respectivamente, 10,15± 6,32 vs. 7,67± 7,21; p = 0,0041
e 12,60± 7,99 vs. 8,96± 7,29; p = 0,00016. Os resultados dos domínios do SGRQ foram,
respectivamente, antes e depois dos sintomas (48,53± 20,41 vs. 32,58± 18,95), Ativi-
dade (69,15± 20,79 vs. 52,42± 23,70), Impacto (32,92± 18,29 vs. 20,27± 16,70), Total
(46,69± 16,90 vs. 32,07± 16,96). Quando correlacionámos o BDI aos domínios do SGRQ, foram
observadas ligeiras correlac¸ões (Sintomas r = 0,22; p = 0,01; Atividade r = 0,28; p = 0,001; Impacto
r = 0,52; p = 2,72; Total r = 0,44; p = 0,17). Também foram observadas correlac¸ões ligeiras quando
correlacionamos o BAI com o SGRQ (Sintomas r = 0,28; p = 0,0009; Atividade r = 0,32; p = 0,0005;
Impacto r = 0,42; p = 7,33; Total r = 0,43; p = 0,74).
Conclusão: Apesar de o PRP melhorar os níveis de depressão e ansiedade, bem como os níveis
de qualidade de vida dos doentes com DPOC, não foram observadas correlac¸ões signiﬁcativas
destas variáveis analisadas.
© 2013 Sociedade Portuguesa de Pneumologia. Publicado por Elsevier España, S.L.U. Todos os
direitos reservados.
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n the past few years, interest in assessing quality of life of
atients with chronic illnesses has increased. This is espe-
ially true of health matters supported by the understanding
f fundamental needs, material and spiritual, and referring
o the ability of living without illness or overcoming difﬁ-
ulties due to morbid conditions. Quality of life related to
ealth is deﬁned, therefore, as the value given to life span,
hen modiﬁed by the perception of physical, psychological,
nd social limitations and limited opportunities, which are
nﬂuenced by illness or health problems.1
Patients with chronic obstructive pulmonary disease
COPD) show changes in pulmonary function, dyspnea, and
eripheral muscle dysfunction. These factors lead to intol-
rance to exercise and progressive worsening of physical
t
o
eonditioning, even limiting daily activities. This can lead
o social isolation, anxiety, depression, and dependence.
hysical disability, loss of productivity, and decrease in qual-
ty of life are substantially aggravated by the progression
f COPD.2 Anxiety and depression are important psychi-
tric disorders in patients with COPD, showing percentages
hat vary, respectively, from 21% to 96% and from 27% to
9%.3 The depressive symptoms have been associated with
educed quality of life, longer hospital stay, more frequent
eadmissions, and even higher mortality rates.4
Documents in the literature show that Pulmonary
ehabilitation Programs (PRP) promote improvements in
unctional exercise capacity and quality of life, and reduce
he sensation of breathlessness, frequency and duration
f hospitalizations, apart from reducing the frequency of
xacerbations.3,5--9 The goal of this study was to evaluate
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were 55.2% with a minimum level and after PRP, 80.0%.
In this particular variable analyzed in this study, we were
able to see more speciﬁcally that there was a decrease in
the moderate level, where before PRP we had 12.8% and
Table 1 Characteristics of 125 patients with COPD treated
in the pulmonary rehabilitation program.
Before PRP After PRP
Age 63.89± 8.88
Sex
Male 61.6%
Female 38.4%
FVC (L) 2.25± 0.87
FVC (% of the predict) 65.6± 21.3
FEV1 (L) 1.16± 0.56
FEV1 (% of the predict) 43.29± 18.6
Pack/years (n)
0 (32) 0
≤30 (29) 17.9± 9.01
>30≤ 50 (20) 41.2± 5.49
>50≤ 100 (33) 76.1± 14.92
>100≤ 150 (7) 126.9± 17.3
>150≤ 360 (4) 217.6± 95.55
BMI (kg/m2) 26.09± 5.04 25.94 ± 4.79
6MWT (m) 397.13± 95.89 452.11 ± 94.28*
PRP, Pulmonary Rehabilitation Program; FVC, forced vital capac-Pulmonary Rehabilitation Program
the effect of a Pulmonary Rehabilitation Program (PRP)
on the levels of anxiety and depression and the qual-
ity of life of patients with chronic obstructive pulmonary
disease.
Methods
In a prospective, study, which included 147 patients with
COPD, 22 patients were not considered for research pur-
poses, as they did not conclude the program. The remaining
125 patients with the diagnosis of COPD who completed the
PRP at Universidade Feevale in Novo Hamburgo -- RS in the
period between May 2007 and December 2011 were ana-
lyzed. The diagnosis of COPD was made according to GOLD
(Global Initiative for Chronic Obstructive Lung Disease) using
clinical history, physical examinations, and the conﬁrmation
of airﬂow obstruction through the ratio of forced expiratory
volume in the ﬁrst second (FEV1) to forced vital capacity
(FVC) as less than 70% of predicted. All patients presented
moderate to severe COPD deﬁned by a FEV1 < 60% of the
predicted value after using a bronchodilator.10
The PRP lasted 12 weeks, and was held on Mondays,
Wednesdays, and Fridays, in the morning. The sessions
lasted 2 h on average, divided into physical activities and
educational lectures. They consisted of a warm-up, aero-
bic physical exercise using a treadmill, upper and lower
body strengthening exercises, and stretching. All assess-
ments were made when the patients entered the program,
before beginning treatment, and after ﬁnishing it.
Apart from the activities above, the patients took part in
weekly educational lectures with an interdisciplinary team
on the following topics: anatomy and pulmonary physiology,
COPD physiopathology, recognizing exacerbation symptoms,
purpose and proper use of medications, airway manage-
ment, energy conservation techniques, oxygen therapy,
beneﬁts of the exercises, nutrition, as well as a support
group coordinated by the psychologist. Relatives were also
invited to participate in these activities. The Beck Scales for
Anxiety and Depression (BDI and BAI), each having 21 items
with four options each, were used to measure levels of anx-
iety and depression in these patients. The options referred
to are minimum depression levels (score from 0 to 11), mild
(from 12 to 19), moderate (from 20 to 35), and severe (from
36 to 63); minimum anxiety levels (score from 0 to 10), mild
(from 11 to 19), moderate (from 20 to 30), and severe (from
31 to 63).11
Saint George’s Respiratory Questionnaire (SGRQ), pre-
viously translated and validated in Brazil in patients with
COPD,12 was used to assess quality of life. The questionnaire
consists of 3 domains -- symptoms, activities, and impact --
with scores from 0 to 100, the highest score representing
poor quality of life in any one of the domains in the total
calculation. A decrease of 4% in any domain was considered
a clinically signiﬁcant difference.
All patients signed the term of informed consent. The
study began after approval by the ethics committee of Uni-
versidade Feevale, process number 4.08.03.08.1239.All variables studied are presented through descriptive
statistics with means and standard deviation. For variables
with normal distribution, comparing pre- and post-PRP val-
ues, the Student t test and the Pearson test were used for301
orrelation with the other variables. The value of statistical
igniﬁcance was considered to be p≤ 0.05.
esults
total of 125 patients with COPD of both genders were
nalyzed, of which 61.6% were male. The age average of
atients was 63.89± 8.8 years and, in relation to the sever-
ty of the illness, all patients could be assigned to moderate
r severe COPD stages, with average FEV1 of 1.16± 0.6 L
43.29± 18.6% predicted). In relation to smoking index,
ccording to number of packs/year, most of the patients
ere stratiﬁed in the range of >50≤ 100. The body mass
ndex (BMI) remained similar in pre- and post-PRP, but the
istance covered in the six-minute walk test (6MWT) was
igniﬁcantly greater post-PRP, as shown in Table 1.
Regarding the results of the anxiety and depression varia-
les, we obtained (10.15± 6.32 vs. 7.67± 7.21;  = 2.48
= 0.0041) and (12.60± 7.99 vs. 8.96± 7.29;  = 3.64
= 0.00016) as averages of BAI and BDI before and after
RP, respectively, demonstrating improvement in anxiety
nd depression after PRP. When analyzing Tables 2 and 3,
e observed that participation in the PRP led to a decrease
n the levels of anxiety and depression of the patients (57.6%
efore PRP and 73.6% after PRP). Only one patient reported
n increase in anxiety levels considered severe after PRP. It
as the same in patients with depression: before PRP thereity; FEV1, forced expiratory volume in the ﬁrst second; BMI,
Body Mass Index, m, meters, kg/m2, kilograms per square meter;
6MWT, six-minute walk test, n, number.
* p≤ 0.001 (test T de Student).
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Table 2 Comparison of results of 125 patients analyzed
with BAI and BDI before and after PRP.
BAI BDI
Before After Before After
10.15± 6.32 7.67± 7.21** 12.60± 7.99 8.96± 7.29*
BAI, beck anxiety inventory; BDI, beck depression inventory.
* p < 0.0041.
** p < 0.00016 (Student T Test matched).
Table 3 Distribution of 125 patients with COPD according
to levels of anxiety and depression before and after the PRP.
Degrees BAI n (%) BDI n (%)
Before After Before After
Minimum 72 (57.6) 92 (73.6) 69 (55.2) 100 (80.0)
Mild 36 (28.8) 18 (14.4) 37 (29.6) 20 (16.0)
Moderate 17 (13.6) 14 (11.2) 16 (12.8) 4 (3.3)
Severe 1 (0.8) 3 (2.4) 1 (0.8)
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where the vast majority of the patients who entered the
PRP had high levels of anxiety and depression, which wereBAI, beck anxiety inventory; BDI, beck depression inventory.
fter it was 3.3%. This pattern of behavior in patients was
imilar in relation to decrease in anxiety and depression
evels.
In the quality of life assessed by the SGRQ, we observed
decrease in all domains, including the total, which
emonstrates a signiﬁcant clinical improvement in these
atients, before and after PRP. The results of the domains
f the SGRQ before and after PRP were, respectively:
ymptoms (48.53± 20.41 vs. 32.58± 18.95;  = 15.9),
ctivity (69.15± 20.79 vs. 52.42± 23.70;  = 16.7),
mpact (32.92± 18.29 vs. 20.27± 16.70;  = 12.6), Total
46.69± 16.90 vs. 32.07± 16.96;  = 14.6). The activities
omain, above all, showed greater variation ( 16.7);
his domain was closely connected to physical performance,
eveloped during PRP.
When correlating the variations of the domains of the
GRQ to the variations of the BDI and BAI, the symptoms and
ctivities domains showed weak, although statistically sig-
iﬁcant, correlations, (r = 0.22; p = 0.01 r = 0.28; p = 0.001),
nd (r = 0.2; p = 0.0009 r = 0.32; p = 0.0005), respectively.
he impact domain and the total score showed moderate
orrelations, although with no statistical signiﬁcance, as
hown in Table 4.
r
r
Table 4 Correlation of the variation of SGRQ domains with the v
Domains  BAI () r
Symptoms 15.9 2.48 0.2
Activity 16.7 2.48 0.32
Impact 12.6 2.48 0.42
Total 14.6 2.48 0.43
BAI, beck anxiety inventory; BDI, beck depression inventory.
* p < 0.05.C.C. da Costa et al.
iscussion
ne of the main goals in treating COPD patients is maintain-
ng the quality of life that is determined by several factors,
uch as gender, rates of illness severity, parameters of pul-
onary function, exercise capacity, and performing daily
ife activities, among others.13--15
Many of these variables have been assessed in Pulmonary
ehabilitation Programs, demonstrating an increase in qual-
ty of life after this type of intervention.16--18 However, a
ecent systematic review demonstrated that the factors
hat correlated the most to the health status of these indi-
iduals were dyspnea, depression, anxiety, and exercise
olerance.19 The data analyzed in this study demonstrated
hat depression and anxiety in patients with COPD decreased
fter participating in a PRP and this reﬂected, consequently,
mprovement in their quality of life. However, the correla-
ions of symptoms and activities domains of the SGRQ with
he variables assessed by the Beck inventories were weak,
ut statistically signiﬁcant (p < 0.01).
In this way, we were able to see that the reduction of
ymptoms caused by the illness and improvement in activ-
ties had a positive inﬂuence on anxiety and depression,
educing the percentage of patients classiﬁed as having
ild, moderate, and severe disorders, to minimum level
isorders (Anxiety before PRP 57.5% and after PRP 73.5%;
epression before PRP 55.1% and after PRP 80.4%), even
hough no speciﬁc and individualized interventions were
arried out with members of the group. This improvement
as obtained exclusively by multidisciplinary treatment that
ncluded physical training, educational sessions about the
llness, and a psychological support team. Godoy and Godoy
2003) in a randomized study demonstrated that individual-
zed psychotherapy permitted more signiﬁcant improvement
n anxiety and depression scores, unlike that in the control
roup, which only had physical training.20
One study analyzed patients with COPD who spent 64%
f their time sitting or lying down, and compared them
o healthy individuals of the same age group who spent
ore than half of their time standing or walking.21 Due
o this situation, many patients become heavily dependent
n their families, which results in reinforcing their feel-
ng of helplessness and contributes to a decrease in self
steem, consequently generating more anxious and depres-
ive patients.22 This ﬁts in with the variables in our study,educed after the intervention. Patients with COPD have
eactive depression that can precede or be triggered by a
ariation of the BAI and BDI.
p BDI () r p
0.0009* 3.64 0.22 0.01*
0.0005* 3.64 0.28 0.001*
7.33 3.64 0.52 2.72
0.74 3.64 0.44 0.17
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variety of changes in lifestyle; the intensity and duration
will depend on the value each individual gives to this change,
mainly in daily life activities.23
When we analyze quality of life in relation to the SGQR
domains in our study, we can observe that, the activities
domain showed a greater variation compared to the others
( 16.7). However in a study where two questionnaires were
used to assess quality of life, among them the SGQR, the
domain with the greatest variation was impact ( 28.64),
which also correlated signiﬁcantly to the BDI (p < 0.01). This
was not observed with the data collected in this study,
although there was moderate correlation (p = 7.33).24 How-
ever, in a study developed with 81 patients with COPD the
conclusion reached was that changes in the BAI were not sig-
niﬁcantly associated with changes in the domains of SGQR.25
In another study, exercise capability, quality of life, and
psychic suffering were assessed in 134 patients with COPD
after 4 weeks of training in a Pulmonary Rehabilitation
Program, conﬁrming that this intervention improved qual-
ity of life, exercise capability, and reduced depression in
these patients.26 A further study conﬁrmed that depressed
patients with COPD have an almost three times greater risk
of exacerbation of the respiratory illness, in comparison with
non-depressed patients.4 In two other studies a strong asso-
ciation between the presence of depressive symptoms and
the increase of exacerbation rates was identiﬁed.27,28 In this
way, the symptoms of anxiety and depression can have even
more negative consequences on patients with COPD.
The quality of life, as well as recognition of all the fac-
tors that inﬂuence it, is extremely important for elaborating
medical and non-medical interventions. As pulmonary reha-
bilitation is a multidisciplinary approach, which includes
physical training as a strategy for recovering independence
and execution of daily life activities, the extended duration
of this intervention potentially offers greater beneﬁts, but
is not economically feasible.29 Godoy et al. (2009) analyzed
the effects after 24 months of a PRP on levels of anxi-
ety, depression, quality of life, and physical performance
in 30 patients with COPD. They concluded that the beneﬁts
obtained from PRP at these levels lasted throughout the 24
months, even with lower values.3
A major limitation of this study was not using a speciﬁc
instrument for assessing the daily life activities of patients
before and after the PRP. However, the SGQR questionnaire
gives the information as perceived by the patients them-
selves regarding their illness in its domains, and the fact that
the activities domain was the one with the greatest variation
indicates improvement in their execution of these activities.
We can conclude that the PRP was able to improve rates
of anxiety and depression and quality of life in patients with
COPD, and also made it possible to observe a weak, but sig-
niﬁcant, correlation between anxiety and depression rates
and the symptoms and activities domains, highlighting dys-
pnea as a cardinal symptom in COPD and loss of capacity in
performing daily life activities as a fundamental component
of the illness.Ethical disclosures
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